Overview
MedEnvision is a trusted provider of efficiency solutions in orthopaedic surgery. The company offers the Gripper™ System, a retraction positioning tool applicable in hip, knee and shoulder surgery, and the EsySuit™ Range. Their tools aim to bring simplicity and efficiency to orthopaedic operating rooms.
Key people
In the news
- A smoother surgery starts with the right setup. The MedEnvision Gripper™ System helps create a stable surgical field, allowing surgeons to control both retractor position and tissue tension with confidence during total shoulder arthroplasty. Learn more at medenvision.com. #GripperSystem #HipArthroplasty #THA #Orthopaedics #ORWorkflow #MedEnvision
- 𝗗𝗿𝗮𝗽𝗶𝗻𝗴 𝗮 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗶𝗻 𝘂𝗻𝗱𝗲𝗿 𝗮 𝗺𝗶𝗻𝘂𝘁𝗲 𝗶𝘀𝗻'𝘁 𝘄𝗶𝘁𝗰𝗵𝗰𝗿𝗮𝗳𝘁. 𝗜𝘁'𝘀 𝘁𝗵𝗲 𝗠𝗲𝗱𝗘𝗻𝘃𝗶𝘀𝗶𝗼𝗻 𝗘𝘀𝘆𝗦𝘂𝗶𝘁™ 𝗥𝗮𝗻𝗴𝗲. Forget the tricks. The EsySuit™ Range makes patient preparation fast and consistent, with draping completed in under one minute. Less draping. More surgery. No magic required. Discover the EsySuit™ Range at medenvision.com Happy Halloween! 🎃 #EsySuit #Orthopaedics #SurgicalEfficiency #OperatingRoom #MedEnvision
- 𝗘𝘀𝘆𝗦𝘂𝗶𝘁™ 𝗦𝘂𝗽𝗶𝗻𝗲 - 𝗟𝗲𝘀𝘀 𝗱𝗿𝗮𝗽𝗶𝗻𝗴, 𝗺𝗼𝗿𝗲 𝘀𝘂𝗿𝗴𝗲𝗿𝘆 Get more surgery done and reduce waste, with the EsySuit™ Supine drape. The EsySuit Supine reduces draping time for DAA THA to less than 1 minute, and facilitates standardized and streamlined patient preparation in the OR. Moreover, due to its smart design, the EsySuit™ Supine drape only takes 9.6m² of fabric, generating less waste compared to traditional draping solutions. Find more information on https://lnkd.in/ey_-RWsU. #LessDrapingMoreSurgery
- Together with the team, I am extremely proud to share this important moment for MedEnvision. Our new partnership with TA Associates marks a major milestone, and we are grateful for the trust and commitment that made it possible. We are very much looking forward to building an ever-stronger company, one that supports orthopaedic surgeons in their daily mission to help patients worldwide move freely. Dries Goyens Chief Executive Officer MedEnvision TA Associates - Smile Invest
- TA is pleased to announce a strategic investment in MedEnvision, a Belgian medtech company. MedEnvision’s Efficient Surgery (ESY) solution, built around its Gripper™ and EsySuit™ products, standardizes workflows for hip, knee, and shoulder replacement procedures. As healthcare providers seek to improve outcomes and operational efficiency, we believe MedEnvision’s advanced technology and commitment to innovation position the Company well to meet the evolving needs of orthopedic surgical teams and hospitals. We look forward to
- Together with the team, I am extremely proud to share this important moment for MedEnvision. Our new partnership with TA Associates marks a major milestone, and we are grateful for the trust and commitment that made it possible. We are very much looking forward to building an ever-stronger company, one that supports orthopaedic surgeons in their daily mission to help patients worldwide move freely. Dries Goyens Chief Executive Officer MedEnvision Smile Invest - TA Associates
- Amerikaanse miljoenen voor Kempense operatiespecialist MedEnvisionHet investeringsfonds TA Associates wordt de nieuwe meerderheidsaandeelhouder van MedEnvision, een bedrijf uit Westerlo dat gespecialiseerd is in instrumenten die chirurgen en verplegers helpen bij orthopedische operaties. Het Belgische Smile Invest, de oprichters en het management herinvesteren mee.
De Tijd Ondernemen · 22 Oct 2026
- We’re proud to share that TA Associates has agreed to invest in MedEnvision as its new majority shareholder. The existing shareholders (the founders, management and Smile Invest) are all reinvesting significantly. 🚀 Since we partnered in 2024, MedEnvision has accelerated its US growth, more than doubled its sales, strengthened its presence in more than 26 countries, and expanded its Efficient Surgery (ESY) solution (Gripper™, EsySuit™ and retractors) from hip to knee and shoulder surgery. These tools make orthopaedic surgery easier,
Something wrong or missing? Send an update. Fixed within 24 hours.